Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
nevirapine, Quantity: 200 mg
Sun Pharma ANZ Pty Ltd
Nevirapine
Tablet, uncoated
Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; povidone; sodium starch glycollate type A
Oral
14, 60, 100
(S4) Prescription Only Medicine
Nevirapine in combination with antiretroviral agents is indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when Nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.
Visual Identification: White to off-white, oval-shaped, uncoated tablets with a break line on both sides and debossed with 'RX921' on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-11-07